共 19 条
[1]
Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2005, 23 (24)
:5568-5577
[3]
RANDOMIZED COMPARISON OF CISPLATIN, METHOTREXATE, BLEOMYCIN AND VINCRISTINE (CABO) VERSUS CISPLATIN AND 5-FLUOROURACIL (CF) VERSUS CISPLATIN (C) IN RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PHASE-III STUDY OF THE EORTC HEAD AND NECK-CANCER COOPERATIVE GROUP
[J].
ANNALS OF ONCOLOGY,
1994, 5 (06)
:521-526
[5]
Goldstein NI, 1995, CLIN CANCER RES, V1, P1311
[6]
Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival
[J].
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE,
1998, 90 (11)
:824-832
[7]
Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter
[J].
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE,
1998, 90 (14)
:1080-1087